Location History:
- Barenklau, DE (2001)
- Bärenklau, DE (2007 - 2008)
Company Filing History:
Years Active: 2001-2008
Title: Birgit Lichtenberg-Kraag: Innovator in Alzheimer's Disease Research
Introduction
Birgit Lichtenberg-Kraag is a prominent inventor based in Bärenklau, Germany. She has made significant contributions to the field of Alzheimer's disease research, holding a total of 3 patents. Her work focuses on the diagnosis and treatment of this debilitating condition, showcasing her dedication to advancing medical science.
Latest Patents
Lichtenberg-Kraag's latest patents include innovative tools for the diagnosis and treatment of Alzheimer's disease. One of her inventions relates to epitopes of the tau protein that are specifically phosphorylated in tau protein from Alzheimer paired helical filaments. This invention also addresses the protein kinases responsible for the phosphorylation of tau protein amino acids, leading to the generation of antibodies specific for these epitopes. Furthermore, her patents encompass pharmaceutical compositions aimed at treating or preventing Alzheimer's disease, as well as diagnostic methods for detecting the condition. Another aspect of her work involves methods for testing drugs that can dissolve Alzheimer paired helical filaments or prevent their formation.
Career Highlights
Birgit Lichtenberg-Kraag is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., where she continues her research and development efforts. Her work has been instrumental in enhancing our understanding of Alzheimer's disease and its underlying mechanisms.
Collaborations
Lichtenberg-Kraag has collaborated with notable researchers in her field, including Eckhard Mandelkow and Jacek Biernat. These partnerships have further enriched her research and contributed to the advancement of knowledge in Alzheimer's disease.
Conclusion
Birgit Lichtenberg-Kraag is a trailblazer in Alzheimer's disease research, with a focus on innovative diagnostic and therapeutic tools. Her contributions are vital in the ongoing battle against this challenging condition, and her work continues to inspire future advancements in medical science.